Omalizumab outperforms oral immunotherapy in multi-food allergy treatment
Food allergy is a common condition that significantly impacts patients' quality of life and carries the risk of life-threatening anaphylaxis.1,2 Until recently, treatment options were largely limited to lifelong allergen avoidance.2 However, two Food and Drug Administration (FDA)-approved therapies